Literature DB >> 27111599

Recent insight into the biological activities of synthetic xanthone derivatives.

Irshad Ahmad1.   

Abstract

Xanthones are a class of oxygen containing heterocyclic compounds with a broad range of biological activities, and they have prominent significance in the field of medicinal chemistry. Xanthone is an attractive scaffold for the design and development of new drugs due to its promising biological activities, primarily as anticancer, antimalarial, antimicrobial, anti-HIV, anticonvulsant, anticholinesterase, antioxidant, anti-inflammatory, and as inhibitors of several enzymes like α-glycosidase, topoisomerase, protein kinase, aromatase, etc. In this review, we have compiled and discussed recent developments on the pharmacological profile of synthetic xanthone derivatives for different therapeutic targets. The review highlights the therapeutic significance of xanthones and offers support in the development of new xanthone derivatives as therapeutic agents.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Anticancer; Biological activities; Therapeutic agents; Xanthones

Mesh:

Substances:

Year:  2016        PMID: 27111599     DOI: 10.1016/j.ejmech.2016.03.058

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  17 in total

1.  Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.

Authors:  Elirosa Minniti; Jo Ann W Byl; Laura Riccardi; Claudia Sissi; Michela Rosini; Marco De Vivo; Anna Minarini; Neil Osheroff
Journal:  Bioorg Med Chem Lett       Date:  2017-09-08       Impact factor: 2.823

Review 2.  Recent progress in selective estrogen receptor downregulators (SERDs) for the treatment of breast cancer.

Authors:  Irshad Ahmad; Shimy Mathew; Sofia Rahman
Journal:  RSC Med Chem       Date:  2020-03-06

Review 3.  Fluorescent indicator displacement assays to identify and characterize small molecule interactions with RNA.

Authors:  Sarah L Wicks; Amanda E Hargrove
Journal:  Methods       Date:  2019-04-30       Impact factor: 3.608

Review 4.  An insight into the therapeutic potential of quinazoline derivatives as anticancer agents.

Authors:  Irshad Ahmad
Journal:  Medchemcomm       Date:  2017-04-07       Impact factor: 3.597

5.  Quinoxaline Derivatives as Antiviral Agents: A Systematic Review.

Authors:  Marc Montana; Vincent Montero; Omar Khoumeri; Patrice Vanelle
Journal:  Molecules       Date:  2020-06-16       Impact factor: 4.411

6.  Enantiomeric Resolution and Docking Studies of Chiral Xanthonic Derivatives on Chirobiotic Columns.

Authors:  Ye' Zaw Phyo; Sara Cravo; Andreia Palmeira; Maria Elizabeth Tiritan; Anake Kijjoa; Madalena M M Pinto; Carla Fernandes
Journal:  Molecules       Date:  2018-01-11       Impact factor: 4.411

7.  α-Mangostin Alleviated Lipopolysaccharide Induced Acute Lung Injury in Rats by Suppressing NAMPT/NAD Controlled Inflammatory Reactions.

Authors:  Mengqing Tao; Jia Jiang; Lin Wang; Yan Li; Qingcheng Mao; Jiyang Dong; Jian Zuo
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-10       Impact factor: 2.629

Review 8.  Research progress in the biological activities of 3,4,5-trimethoxycinnamic acid (TMCA) derivatives.

Authors:  Zefeng Zhao; Huanhuan Song; Jing Xie; Tian Liu; Xue Zhao; Xufei Chen; Xirui He; Shaoping Wu; Yongmin Zhang; Xiaohui Zheng
Journal:  Eur J Med Chem       Date:  2019-04-06       Impact factor: 6.514

9.  Chiral Derivatives of Xanthones: Investigation of the Effect of Enantioselectivity on Inhibition of Cyclooxygenases (COX-1 and COX-2) and Binding Interaction with Human Serum Albumin.

Authors:  Carla Fernandes; Andreia Palmeira; Inês I Ramos; Carlos Carneiro; Carlos Afonso; Maria Elizabeth Tiritan; Honorina Cidade; Paula C A G Pinto; M Lúcia M F S Saraiva; Salette Reis; Madalena M M Pinto
Journal:  Pharmaceuticals (Basel)       Date:  2017-05-31

10.  Potential Antiviral Xanthones from a Coastal Saline Soil Fungus Aspergillus iizukae.

Authors:  Hui-Hui Kang; Huai-Bin Zhang; Mei-Jia Zhong; Li-Ying Ma; De-Sheng Liu; Wei-Zhong Liu; Hong Ren
Journal:  Mar Drugs       Date:  2018-11-15       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.